Jatka sisältöön
Products
Technology
Research
News
Company
Careers
Contact
Adaptos®Vet
01.03.2023
Pasi Kankaanpää starts as the CEO of Biomendex on the first of March 2023
06.05.2022
The 1st Distribution Agreement for Adaptos®Vet
11.06.2021
Adaptos® clinical study started with Hospital Orton, Oral and Planmeca
03.05.2021
Biomendex closed 1 M€ investment round
01.09.2020
Biomendex held bone regeneration -seminar
08.04.2020
More functional synthetic bone graft substitutes are developed with reliable porosity analysis and properly chosen analysis methods
30.09.2019
EU to award Biomendex Oy up to €2,2M funding for entry to the orthopedic implant market
30.09.2019
High porosity and bone attachment are crucial elements for a synthetic bone graft – study demonstrates the excellent properties of a novel composite material
Posts navigation
«
1
2